Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma
Paul Shaughnessy, Warren Alexander, Hai Tran, David Ririe, James Splichal, Marilyn Pollack, Carlos Bachier, Charles LeMaistre
Dive into the research topics of 'Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma'. Together they form a unique fingerprint.